Data investigation
We Read FDA's Register of Compounding Facilities. 40 of 98 Have Never Been Inspected.
Original analysis of FDA's published 503B register: 98 facilities, 40 never inspected — and why that headline number is the misleading one.
If a compounded GLP-1 arrives at your door, some pharmacy made it, and you are entitled to know which one and whether anyone has ever walked through the building. For one half of the compounding market there is a federal answer, published and free. We pulled the whole register and went through it.
What the register is
FDA maintains a list of every facility registered under section 503B of the Food, Drug, and Cosmetic Act — outsourcing facilities, the larger compounders that make medication in batches. For each one it publishes the name, the city and state, the date it first registered, the date it most recently re-registered, and the date it was last inspected.[1] On our pull it held 98 facilities.
Forty of the ninety-eight have never been inspected
FDA does not bury this. The inspection column says, in plain words, “Not yet inspected”, and it says it for 40 of the 98 — 41% of the register. That is the number most people would publish, and on its own it is misleading.
The distribution says something different
We checked how long each uninspected facility had been registered. Almost all of them are recent. Of the 40 that have never been inspected, only three have been on the register for three years or more, and none for five. The rest registered within the last two years.
| Facility | Location | Registered since | Years |
|---|---|---|---|
| Bennett Pharmaceuticals of America LLC | Hudson, WI | April 19, 2022 | 4.3 |
| Denver Solutions, LLC, dba Leiters Health | Buena, NJ | July 1, 2022 | 4.1 |
| McGuff Pharmaceuticals, Inc. dba McGuff Outsourcing Solutions | Santa Ana, CA | January 11, 2023 | 3.6 |
Read the other way round, the register looks like an agency keeping up rather than one that has lost track. Of the 58 facilities that have been inspected, 55 were last inspected in 2025 or 2026. Only two have gone more than two years since an inspector was there.
Where they are
The register concentrates in a handful of states: Texas (17), Florida (15), New Jersey (10) and California (9) hold just over half of it between them. That matters mainly because a facility’s state is the thing you can look up next.
How to use this as a buyer
- Ask which pharmacy fills the prescription, by name. Most sellers we track do not publish this. An unnamed pharmacy is a finding in itself.
- Look for that name on the federal register. If it is there, you can see when it registered and when it was last inspected.
- If it is not there, ask which state board licenses it. That is the right follow-up, not an accusation — 503A pharmacies belong to state boards.
- Treat “not yet inspected” as context, not a verdict. On this register it usually means recently registered.
Frequently Asked Questions
References
- 1.U.S. Food and Drug Administration Registered Outsourcing Facilities FDA Human Drug Compounding. 2026. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- 2.U.S. Food and Drug Administration Human Drug Compounding Laws FDA Human Drug Compounding. 2026. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
Related research
Buying Tirzepatide as a Research Chemical: What "Research Use Only" Really Means
"Research use only" is the seller's legal position on what they are handing you, not a grade — and it removes the licensed dispenser, the accountable prescriber and every route to recourse.
7 min read
Compounded Semaglutide and Tirzepatide Are Ending: What to Do Next
The federal permission that made large-scale GLP-1 compounding lawful has closed. Three routes remain, one to avoid, and the questions to ask before you move.
6 min read
Compounded Semaglutide vs Ozempic and Wegovy: What Is Actually Different
Compounded semaglutide can contain the same molecule as Ozempic and Wegovy, but the formulation, the concentration, the dose ladder and the adverse-event record are not the same thing at all.
9 min read
Compounded Tirzepatide Side Effects: The Drug, and the Vial
Most compounded tirzepatide side effects are tirzepatide side effects, documented in the approved product's label and trials. A smaller set comes from the preparation — a pharmacy-set concentration, added ingredients, and an adverse-event pathway that may never count your report.
10 min read
Do You Need a Prescription for Compounded Semaglutide?
Yes — but 503A and 503B do not carry the same requirement, and the gap between them is where the no-prescription pitches live. What each route actually asks for.
5 min read
GLP-1 Eye Risks: Diabetic Retinopathy and NAION Are Not the Same Thing
Two distinct eye questions get merged into one headline. Diabetic retinopathy complications are on the semaglutide label and trace to blood sugar falling fast; NAION is a separate optic-nerve signal that Europe labeled in June 2025 and US labeling still does not mention.
12 min read
Where to get tirzepatide (Mounjaro / Zepbound) online, safely: sellers our editors have checked
These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Care Bare Rx
Knowing which pharmacy fills the vial — it names Belmar Pharmacy
From $199/mo
Get started →Oak
Semaglutide at $119/month, 37% under the register median
From $185/mo
Get started →Direct Meds
Compounded semaglutide at $249/month
From $299/mo
Get started →